Thoracolumbar disc herniation
Conditions
Interventions
Case series:spinal endoscopy
Sponsors
Shanghai Public Health Clinical Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Treatment of thoracolumbar degenerative diseases with spinal endoscopy Inclusion criteria: (1) Low back pain with or without sciatic nerve pain and intermittent claudication; (2) Conservative treatment for more than 3 months has poor results or recurrent symptoms; (3) Oswestry dysfunction index (ODI)>30%; (4) The imaging findings are consistent with clinical manifestations. The responsibility section is clear. 2. Treatment of mild to moderate lumbar spondylolisthesis with spinal endoscopy combined with OLIF technology Inclusion criteria: (1) Low back pain with or without sciatic nerve pain and intermittent claudication; (2) Conservative treatment for more than 3 months has poor results or recurrent symptoms; (3) Oswestry dysfunction index (ODI)>30%; (4) Dynamic X-ray film, CT and MRI showed lumbar spondylolisthesis, the imaging findings were consistent with clinical manifestations, and the responsible segment was a single segment; 3. The use of spinal endoscopy combined with PVP technology to treat late-stage and/or spinal metastases with spinal cord compression: (1) advanced spinal metastases diagnosed by imaging or pathology and/or with spinal cord compression; (2) imaging examination showed space in the spinal canal with symptoms of nerve compression (ESCC types B and C) ), with or without pain and pathological fracture of the vertebral body; (3) Preoperative Tomita score 8-10 points, or modified Tokuhashi score 5-9 points, basically unable to tolerate major surgery; 4. Treatment of spinal tuberculosis with spinal endoscopy technology combined with small anterior incision focus debridement, bone graft fusion, and short-segment internal fixation (1) Diagnosed thoracic and lumbar tuberculosis, with spinal instability, paravertebral abscess, sequestered bone and cavity formation, and unbearable pain requiring surgical treatment; (2) Minimally invasive lesions under endoscopic percutaneous foraminal approach Cleaning, allograft bone grafting combined with posterior percutaneous internal fixation; (3) The efficacy evaluation indicators are mainly tuberculosis cure, pain improvement and quality of life evaluation; (4) The clinical data is complete, and the follow-up time exceeds 12 months.
Exclusion criteria
Exclusion criteria: 1. Treatment of thoracolumbar degenerative diseases with spinal endoscopy: spondylolisthesis instability, unclear responsible segment, infection and tumor, etc.; 2. Treatment of mild to moderate lumbar spondylolisthesis with spinal endoscopy combined with OLIF technology: simple lumbar disc herniation, simple lumbar spinal stenosis, bilateral severe bony spinal stenosis, spondylolisthesis responsible segment >=2 segments, lumbar spondylolisthesis >II degree (Meyerding grade), infection and tumor, etc.; 3. The use of spinal endoscopy combined with PVP technology to treat late-stage and/or spinal metastases with spinal cord compression: (1) Spine metastases were diagnosed by imaging or pathology, but no nerve compression symptoms; (2) Patients who had received high-dose radiotherapy or PVP treatment for spine disease; (3) Acute or active infection lesions in any part of the body, no controller; 4. Treatment of spinal tuberculosis with spinal endoscopy technology combined with small anterior incision focus debridement, bone graft fusion, and short-segment internal fixation: (1) The extent of lesion involvement>1 motion segment; (2) Patients with grade A~C spinal cord injury from American spinal injury association (ASIA); (3) Combined with scoliosis, kyphosis or other spinal deformities or Those with a history of spinal surgery; (4) Combined with other serious diseases such as tumor, brucellosis, ankylosing spondylitis; (5) The lesion is located above the C7 vertebral body or below the S2 vertebral body; (6) Kyphosis >60 degree.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The oswestry disability index;visual analogue scale, VAS;X-ray;MRI;Computer tomography; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of days in hospital;operation time;Bleeding volume;Activity time; | — |
Countries
China
Contacts
Public ContactYu-tong Gu
Shanghai Public Health Clinical Center
Outcome results
None listed